Chargement en cours...
A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours
BACKGROUND: ErbB2 is an attractive target for immunotherapy, as it is a tyrosine kinase receptor overexpressed on tumour cells of different origin, with a key role in the development of malignancy. Trastuzumab, the only humanised anti-ErbB2 antibody currently used in breast cancer with success, can...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3111160/ https://ncbi.nlm.nih.gov/pubmed/21559015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.146 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|